- Spark Newswire

2 minute read

Clinical Research Comparing Effects Of Novel MDMA Matches In Healthy Patients Begins In Switzerland

Today, 5:57 AM

The clinical trial investigating the effects of MDMA analogs in healthy volunteers led by PI Prof. Dr. Matthias Liechti and supported by psychedelics biotech company Mind Medicine Inc. (NASDAQ: MNMD) has begun patient dosing.

MNMD

2 minute read

Toronto Residents Get New Ketamine-Assisted Therapy Option Close To Home

By Lara Goldstein

Today, 5:57 AM

The Neurology Centre of Toronto (NCT), located in a midtown neighborhood and owned by Numinus Wellness Inc. (OTCQX: NUMIF), is offering ketamine-assisted therapy for patients with neurologic conditions diagnoses.

NUMIF

2 minute read

Magic Mushrooms Vs. Psychotherapy For Incurable Cancer Diagnosis Moves Forward In UK Clinical Trials

By Lara Goldstein

Today, 5:57 AM

UK's Medicines and Healthcare products Regulatory Agency (MHRA) approved Psyence Group Inc.

PSYGF

1 minute read

New Batch Of Psilocybin Microdose Capsules Is Ready, Learn All The Details

By Lara Goldstein

Today, 5:57 AM

Canadian-based psychedelics company Nova Mentis Life Science Corp.

NMLSF

2 minute read

Awakn Shares Its Q2 2022 Results, Showing Consistent Growth On Its Second Full Financial Year

By Lara Goldstein

Today, 5:57 AM

Biotech firm leading the Alcohol Use Disorder (AUD) treatment Awakn Life Sciences Corp. (OTCQB: AWKNF) has announced its financial outcomes and business highlights for the three months ended July 31, 2022. During the period, numbers reflected:

AWKNF

2 minute read

Wellbeing Digital Reports 4Q Finances, ‘Three Key Pillars’ Stay Strong

By Lara Goldstein

Today, 5:57 AM

Wellbeing Digital Sciences Inc. (OTC: KONEF) filed its financial results for the quarter ended July 31, 2022 and provided some insight on their most recent businesses. Numbers for the selected period showed:

KONEF

1 minute read

Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction

By Lara Goldstein

Today, 5:57 AM

Life sciences company Revive Therapeutics Ltd. (OTCQB: RVVTF) is advancing its first Phase I/II clinical trial of oral psilocybin for methamphetamine use disorder treatment while also developing an oral psilocybin thin film strip product.

RVVTF

2 minute read

This Psychedelics Company Is Undertaking A 1:50 Reverse Stock Split To Enter NASDAQ

By Lara Goldstein

Today, 5:57 AM

The psychedelics landscape changes quickly. Whether large or small, every biotech company is looking for ways to further advance their research and product & services commercialization.

MNMD

3 minute read

Psychedelics Companies Share Corporate Updates: Numinus, Delix, Tryp And Small Pharma

By Lara Goldstein

Today, 5:57 AM

Numinus Updates On New Acquisition’s Integration And Provides Client Financing Options

DMTTF

2 minute read

Psychedelics Companies Are Teaming Up To Offer Access Veterans

By Lara Goldstein

Today, 5:57 AM

Two psychedelics companies have announced they’ll be collaborating to offer ketamine infusions in the US and psilocybin clinical retreats internationally with a special focus on access needs for veterans.

AWKNF